News | News By Subject | News by Disease News By Date | Search News

Diabetes, Type 1 (insulin dependent) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Agreement Reached After Novo Nordisk A/S (NVO) is Accused of Disguising Salespeople and Dealing Kickbacks     5/2/2017
This Bay Area Biotech is Being Wooed by Drug Giant Novo Nordisk A/S (NVO)     3/10/2017
Alphabet's Verily, Sanofi (SNY) Launch $500 Million Onduo, Joint Venture to Open New HQ in Kendall Square     9/13/2016
Lexicon Pharma (LXRX) Rockets on Late-Stage Diabetes Drug Data     9/12/2016
Pharmaceutical Trade Groups Highlight Research Benefits in New Ad Campaigns     2/25/2016
FDA Clears Eli Lilly (LLY)'s Diabetes Drug Basaglar     12/17/2015
Novo Nordisk A/S (NVO) Finally Bags Diabetes Drug Tresiba U.S. Approval     9/28/2015
Novartis AG (NVS) Launches New Portfolio Of Affordable Medicines for Poor Countries     9/24/2015
Novo Nordisk A/S (NVO)’s Victoza Beats Sanofi (SNY)’s Lixisenatide in Head-to-Head Study, Company Says     9/17/2015
Google (GOOG)'s Life Sciences to Partner with Sanofi (SNY) on Diabetes Therapies and Monitors     9/1/2015
Novo Nordisk A/S (NVO) Pulls the Plug on Expanding Victoza for Type 1 Diabetes     8/27/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Study Shows Novo Nordisk A/S (NVO)'s New Diabetes Drug Tresiba Effective And Safe For Children     9/16/2014

News from Around the Web
Tool IDs Diabetes Patients At Risk For Severe Hypoglycemia, Kaiser Permanente Study     8/22/2017
FDA Warns of Leg, Foot Amputations With Johnson & Johnson (JNJ)'s Diabetes Med, Invokana     5/17/2017
New Test IDs Diabetics Who Are At High Risk Of Kidney Failure, Joslin Diabetes Center Study Reveals     4/19/2017
Bay Area's Livongo Rakes in $52.5 Million     3/17/2017
Artificial Pancreas Race Intensifies Between These 3 Medtech Firms     11/21/2016
Type 1 Diabetes Linked To Epilepsy Risk, China Medical University Children's Hospital Study     4/1/2016
New Findings Could Boost Type 1 Diabetes Treatment, University of Exeter Study     2/29/2016
Infant Weight Gain Linked To Diabetes Risk, Norwegian Institute Of Public Health Study     12/8/2015
Stuff In Yogurt May Decrease Type 1 Diabetes Risk, University of South Florida     11/12/2015
Kids With Type 1 Diabetes At Risk For Mental Health Problems, Karolinska Institute Reveals     2/19/2015
Novel "Smart" Insulin Can Sense Blood Sugar Levels, University of Utah Study     2/10/2015
Broad Institute Researchers Find Link Between Microbiome, Type 1 Diabetes     2/9/2015
Young Kids With Type 1 Diabetes Have Slower Brain Growth, Nemours Children's Clinic Study     12/22/2014
Popular Blood Pressure Drug May Reverse Type 1 Diabetes, University of Alabama at Birmingham Study     11/12/2014
Gluten-Free Diet Cuts Type 1 Diabetes Risk, University of Copenhagen Study     5/9/2014

Press Releases
Lexicon Pharma (LXRX) Announces Opt-In Decision For U.S. Co-Promotion Of Sotagliflozin With Sanofi In Type 1 Diabetes     8/1/2017
Caladrius Biosciences (CLBS) Announces That 50% Of Subjects Have Been Treated In The Phase II Clinical Trial Of CLBS03 For Type 1 Diabetes     7/19/2017
Provention Bio Announces Clinical Program Focused On Intercepting And Preventing The Onset Of Type 1 Diabetes     7/18/2017
SymbioCellTech, LLC Release: 'Neo-Islets', A Major Advance Toward A Functional Cure Of Type-1 Diabetes     7/5/2017
Medtronic (MDT) Announces Outcomes-Based Agreement With Aetna For Type 1 And Type 2 Diabetes Patients     6/26/2017
Medtronic (MDT) Announces Outcomes-Based Agreement With Aetna For Type 1 And Type 2 Diabetes Patients     6/26/2017
Zealand Pharma  (ZEAL.CO) Release: Phase IIa Trial Results Support Development Of Dasiglucagon In The ILet Pump System For Type 1 Diabetes     6/22/2017
Xeris Pharma Announces New Results From Ready-To-Use Liquid Glucagon Clinical Development Program     6/16/2017
Phase I Clinical Study Results Of REMD Biotherapeutics’ Lead Product Candidate, REMD-477, Demonstrate Reduced Need For Insulin And Improved Blood Glucose Levels For Patients With Type 1 Diabetes     6/14/2017
American Diabetes Association Release: Glucagon-Blocking Drug Reduces Need For Insulin And Improves Blood Glucose Levels For Patients With Type 1 Diabetes     6/14/2017
American Diabetes Association Release: Autoantigen GAD-Vaccine Is Safe For Children At High Risk For Developing Type 1 Diabetes     6/13/2017
American Diabetes Association Release: Hybrid Closed-Loop System Demonstrates Effectiveness In Controlling Glucose Levels In Children And Adults With Type 1 Diabetes     6/13/2017
Mylan (MYL) And BioCon (BIOCON.NS) Present Clinical Data On Insulin Glargine At The American Diabetes Association's 77th Scientific Sessions     6/12/2017
American Diabetes Association Release: Long-Term Metformin Treatment Found To Reduce Risk Of Heart Disease In Adults With Type 1 Diabetes     6/12/2017
Lexicon Pharma (LXRX) Surges On Positive Phase III For New Diabetes Drug     6/9/2017

//-->